Anthem Biosciences Ltd. (ANTHEM) Share Price Hits Fresh 52-Week High
- August 11, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Ltd. Share Price rose 2.74% to Rs 876.75 after touching a fresh 52-week high of Rs 887. The company’s market capitalisation stood at Rs 47,371.35 crore.
Anthem Biosciences Ltd. Share Price climbed to Rs 876.75 on 11 August 2026, up Rs 23.40 or 2.74% from the previous close of Rs 853.35, after hitting a fresh 52-week high of Rs 887. With a market capitalisation of Rs 47,371.35 crore, the stock has entered the day’s market conversation as a one-year high event in the Healthcare space.
For investors tracking Anthem Biosciences Ltd. Share Price Today, the verified data confirms a strong price move and a new yearly high, but it does not establish a company-specific catalyst behind the rally. That distinction matters. In Stock Market Today coverage, many stocks move on price momentum alone, and this appears to be one such case based strictly on the supplied figures.
Anthem Biosciences Ltd. Stock News is drawing attention because the stock opened at Rs 853.50, moved as high as Rs 887, held well above the previous close, and generated turnover of Rs 7.37 crore on volume of 84,043 shares. For readers using Univest for Anthem Biosciences Ltd. Share Price Live tracking, the key questions now shift from what happened to how the move fits into valuation, profitability, sector positioning and peer comparison.
Anthem Biosciences Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 876.75 |
| Previous Close | Rs 853.35 |
| Today's Change | +Rs 23.4 (+2.74%) |
| Day Open | Rs 853.5 |
| Fresh 52-Week High | Rs 887 |
| Day Low | Rs 853.35 |
| Current Volume | 84,043 |
| Turnover | Rs 7.37 crore |
| Market Capitalisation | Rs 47,371.35 crore |
Anthem Biosciences Ltd. (ANTHEM) traded at Rs 876.75. versus the previous close of Rs 853.35, a rise of 2.74%. The stock opened at Rs 853.5, reached Rs 887, touched Rs 853.35. Reported volume was 84,043.
Anthem Biosciences Ltd. Share Price Today shows a clear 52-week high event, with the stock opening near the previous close, rising intraday to Rs 887, and trading at Rs 876.75 at the time of this update. The move highlights active participation and keeps the stock firmly on the radar in Share Market Today discussions.
The day began at Rs 853.50 versus a previous close of Rs 853.35, indicating a largely steady start before momentum built during the session. The stock then moved to an intraday high of Rs 887, which now stands as the fresh 52-week high, while the day’s low remained Rs 853.35. That means the low matched the previous close, and the session’s price action was defined by upward expansion rather than an early gap-driven spike.
At the latest traded price of Rs 876.75, Anthem Biosciences Ltd. Share Price was up Rs 23.40 for the day. In percentage terms, the gain stood at 2.74%, a meaningful move for a stock already carrying a market capitalisation of Rs 47,371.35 crore. Turnover came in at Rs 7.37 crore with traded volume of 84,043 shares, confirming that the stock’s one-year high was accompanied by visible market activity.
For traders and long-term trackers alike, the important takeaway is straightforward: Anthem Biosciences Ltd. Share Price has not only touched a fresh 52-week peak, but it also remained above both the opening level and the previous close after reaching that high. That is why the stock is appearing in 52 Week High Stocks and Market Movers conversations today. The next step is to examine whether the fundamentals provide context for this rising attention.
Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 47,371.35 crore |
| P/E Ratio | 40.09x |
| P/B Ratio | 9.77x |
| ROE | 28.21% |
| ROCE | 26.35% |
Anthem Biosciences Ltd. was valued at a P/E ratio of 40.09x, a P/B ratio of 9.77x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 40.09x |
| Benchmark Median P/E | 20.84x |
| Benchmark Average P/E | 76.55x |
| Benchmark P/E Range | 0x to 3,396.3x |
| Company P/B Ratio | 9.77x |
| Benchmark Median P/B | 1.93x |
| Company ROE | 28.21% |
| Benchmark Median ROE | 10.77% |
| Company ROCE | 26.35% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 47,371.35 crore |
| Benchmark Median Market Cap | Rs 142.3 crore |
Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare.
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 40.09x, which is above the benchmark median of 20.84x, a difference of +92.37%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Anthem Biosciences Ltd. (ANTHEM) has a ROE of 28.21%, which is above the benchmark median of 10.77%, a difference of +161.93%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 26.35%, which is above the benchmark median of 13.35%, a difference of +97.38%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd. | KPL | 2,707.2 | 40.09 | 9.77 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,631.45 | 66.92 | 10.59 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,601.85 | 34.14 | 7.04 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,513.58 | 181.97 | 3.36 | 13.9 | 12.97 |
| NGL Fine-Chem Ltd. | NGLFINE | 2,118.6 | 44.48 | 6.5 | 27.9 | 33.91 |
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 40.09x compared with the displayed peer median of 44.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 18.65% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 22.17%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 47,371.35 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences Ltd.
Anthem Biosciences Ltd. Share Price is attracting attention because the supplied data shows a fresh one-year high backed by a meaningful daily gain, a large market capitalisation and profitability ratios that compare well with sector benchmarks.
- Fresh price event: The stock touched Rs 887, marking a new 52-week high, and was last at Rs 876.75, up 2.74% on the day.
- Intraday strength: The session opened at Rs 853.50, matched the previous close area at the low of Rs 853.35, and then pushed higher.
- Market activity: Volume stood at 84,043 shares with turnover of Rs 7.37 crore, keeping the stock visible in Stocks in News and Market Movers screens.
- Fundamental profile: P/E is 40.09, P/B is 9.77, ROE is 28.21% and ROCE is 26.35%.
- Sector position: ROE and ROCE are above the Healthcare benchmark medians and averages, while market cap is far above the supplied sector averages.
- Peer context: The company is significantly larger than the listed peers provided, with competitive profitability metrics across the comparison set.
About Anthem Biosciences Ltd.
Anthem Biosciences Ltd. is part of the Healthcare sector. Within the supplied comparison data, the company is being assessed alongside businesses in Pharmaceuticals & Drugs and related healthcare segments, which places it within a market ecosystem where valuation, profitability and scale are closely tracked by investors.
Based on the verified dataset used for this article, Anthem Biosciences Ltd. is currently best understood through its market positioning rather than a long operating description. The company has a market capitalisation of Rs 47,371.35 crore, which is substantially larger than the peer companies listed in the same comparison set. That makes Anthem Biosciences Ltd. a prominent stock in the Healthcare space from a market-value perspective.
For readers following Anthem Biosciences Ltd. NSE, Anthem Biosciences Ltd. BSE and Anthem Biosciences Ltd. Share News coverage, today’s relevance comes from a combination of market scale, profitability ratios and a fresh 52-week high. On Univest, that mix tends to place a stock at the intersection of price action tracking and deeper stock analysis, especially when valuation and sector benchmarks are also notable.
Track Anthem Biosciences Ltd. Share Price on Univest
Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors using Univest can track Anthem Biosciences Ltd. Share Price through live price updates, 52-week levels, market capitalisation, valuation ratios and comparative market insights. That makes it easier to follow not only Anthem Biosciences Ltd. Share Price Today but also how the stock sits against sector benchmarks and peers over time.
Univest also helps users monitor core stock-analysis inputs such as P/E, P/B, ROE, ROCE and broader market context around Anthem Biosciences Ltd. Stock Performance. After a move like today’s fresh 52-week high, those data points become especially useful for separating simple momentum from a broader fundamental and sector narrative.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Anthem Biosciences Ltd. Share Price today?
Ans. Anthem Biosciences Ltd. Share Price was Rs 876.75 at the time of this update. The stock was up Rs 23.40, or 2.74%, from the previous close of Rs 853.35 after touching a fresh 52-week high.
Why is Anthem Biosciences Ltd. Share Price rising today?
Ans. The supplied data confirms that Anthem Biosciences Ltd. Share Price rose 2.74% and hit a fresh 52-week high of Rs 887. However, the verified figures do not establish any company-specific catalyst for today’s move.
What is the new 52-week high of Anthem Biosciences Ltd.?
Ans. The fresh 52-week high for Anthem Biosciences Ltd. is Rs 887. The stock opened at Rs 853.50, traded as low as Rs 853.35, and remained elevated at Rs 876.75 during the session.
How much did Anthem Biosciences Ltd. gain today?
Ans. Anthem Biosciences Ltd. gained Rs 23.40 on the day, which translates into a 2.74% rise from the previous close of Rs 853.35. That move helped push the stock to a new one-year high.
What does today’s price action in Anthem Biosciences Ltd. show?
Ans. Today’s price action shows upward intraday strength. Anthem Biosciences Ltd. opened at Rs 853.50, matched the previous close zone at the low of Rs 853.35, and then advanced to a 52-week peak of Rs 887.
What is the market capitalisation of Anthem Biosciences Ltd.?
Ans. Anthem Biosciences Ltd. has a market capitalisation of Rs 47,371.35 crore. In the supplied Healthcare benchmark, that is far above the median of Rs 142.30 crore and the average of Rs 472.15 crore.
What are the key valuation ratios of Anthem Biosciences Ltd.?
Ans. Anthem Biosciences Ltd. is trading at a P/E ratio of 40.09 and a P/B ratio of 9.77. These multiples are above the Healthcare benchmark medians of 20.84 for P/E and 1.93 for P/B.
How does Anthem Biosciences Ltd. compare with its peers?
Ans. Anthem Biosciences Ltd. has a much larger market capitalisation than the supplied peers, while its profitability compares favourably with most of them. Its P/E of 40.09 is below Beta Drugs and Sai Parenteral's, but above Dr Agarwals.
What should investors monitor next in Anthem Biosciences Ltd.?
Ans. Investors can monitor whether Anthem Biosciences Ltd. Share Price holds near the fresh 52-week high, while also tracking valuation ratios, sector comparisons and any future company disclosures that could add context to the move.
